article thumbnail

Time to look Beyond Compulsory Licenses? A Glimpse at the Ribociclib Case

SpicyIP

Image from here Recently, the Print reported that Novartis and Eli Lilly have voiced their opposition to the idea of compulsory licensing (“ CL ”) for breast cancer medications, Ribociclib and Abemaciclib. million breast cancer cases are expected globally by 2050. It also says that no licenses were given out. of GDP in FY23.

article thumbnail

COP27 and the UK energy sector – between a rock and a hard place

Herbert Smith Freehills

The UK's climate change agenda will be complicated by an energy market under intense pressure and policy in flux . In 2021 the UK enshrined in law a pledge to reduce emissions by 78% by 2035 (compared to 1990 levels), with an overarching commitment to reach net zero by 2050. UK CLIMATE COMMITMENTS.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

COP26 – Trends in Latin America

Herbert Smith Freehills

As part of its Decarbonization Plan, Costa Rica is committed to reaching zero carbon emissions by 2050. Brazil also passed a gas law opening the LNG market to private companies, which faced criticism contending that using LNG to replace coal is not an effective strategy to reduce emissions. Ambiguous Approaches to Climate Change.

article thumbnail

COP26 – Trends in Latin America

Herbert Smith Freehills

As part of its Decarbonization Plan, Costa Rica is committed to reaching zero carbon emissions by 2050. Brazil also passed a gas law opening the LNG market to private companies, which faced criticism contending that using LNG to replace coal is not an effective strategy to reduce emissions. Ambiguous Approaches to Climate Change.

article thumbnail

Sunday Surprises

The IPKat

The Institute for Intellectual Property and Market Law (IFIM) at Stockholm University is proud and delighted to announce its new, in-person event to be held in English at Stockholm University on Thursday, June 2, 2022, on the topic: 'The DSM Directive 3 years on: The Polish challenge to Article 17 and the national transposition maze'.